Delayed Treatment with Histone Deacetylase Inhibitors Promotes Stroke Recovery

J Neurosci. 2017 Dec 13;37(50):12088-12090. doi: 10.1523/JNEUROSCI.2615-17.2017.

Authors

Timal S Kannangara^{1

2}, Marc A Vani^{3

2}

Affiliations

¹ Department of Cellular and Molecular Medicine, and Brain and Mind Research Institute, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada, and tkannang@uottawa.ca.
² Heart and Stroke Foundation Canadian Partnership for Stroke Recovery, Ottawa, Ontario K1G 5Z3, Canada.
³ Department of Cellular and Molecular Medicine, and Brain and Mind Research Institute, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada, and.

No abstract available

Publication types

Comment

MeSH terms

Histone Deacetylase 2
Histone Deacetylase Inhibitors*
Humans
Stroke
Time-to-Treatment*

Substances

Histone Deacetylase Inhibitors
HDAC2 protein, human
Histone Deacetylase 2